[A new Topo to targeted management of Angelman syndrome?].
Bernard
B
Dan
Karine
K
Pelc
Guy
G
Chéron
D000483:Alleles; D017204:Angelman Syndrome / Q000188:drug therapy* / Q000235:genetics; D002648:Child; D002675:Child, Preschool; D044127:Epigenesis, Genetic / Q000187:drug effects / Q000235:genetics; D005220:Fathers; D018392:Genomic Imprinting / Q000235:genetics; D006801:Humans; D008954:Models, Biological; D058990:Molecular Targeted Therapy / Q000379:methods / Q000639:trends*; D009154:Mutation / Q000502:physiology; D059004:Topoisomerase I Inhibitors / Q000627:therapeutic use; D019772:Topotecan / Q000627:therapeutic use*; D044767:Ubiquitin-Protein Ligases / Q000235:genetics / Q000378:metabolism
D059004:Topoisomerase I Inhibitors; D019772:Topotecan; C471639:UBE3A protein, human; D044767:Ubiquitin-Protein Ligases